Columvi: Regulatory submission in Japan for r/r DLBCL in 2026 (Chugai) - Oct 27, 2026 - Q3 FY2026 Results: Regulatory submission in Japan for r/r MCL in 2028
Japan filing • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Mantle Cell Lymphoma • Oncology
|